Skip to main navigation
Skip to search
Skip to main content
Region Zealand Home
Help & FAQ
Link opens in a new tab
Dansk
English
Search content at Region Zealand
Home
Profiles
Research units
Projects
Research output
Prizes
Activities
Courses
Press/Media
Impacts
One-Dose Human Papillomavirus Vaccination and the Risk of Genital Warts: A Danish Nationwide Population-based Study
Louise Baandrup
, Christian Dehlendorff
, Susanne K Kjaer
*
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
Research
›
peer-review
Overview
Fingerprint
Fingerprint
Explore the research areas of 'One-Dose Human Papillomavirus Vaccination and the Risk of Genital Warts: A Danish Nationwide Population-based Study'.
Sort by
Weight
Alphabetically
Keyphrases
National Cohort Study
100%
Genital Warts
100%
Human Papillomavirus Vaccine
100%
One Dose
100%
Confidence Interval
66%
Vaccine Effectiveness
50%
Calendar Time
50%
2-dose
50%
Vaccination
33%
Incidence Rate
33%
Age Groups
16%
High-risk Human Papillomavirus (HR-HPV)
16%
Poisson Regression
16%
First Occurrence
16%
Unvaccinated
16%
Vaccination Status
16%
Quadrivalent Human Papillomavirus Vaccine
16%
Herd Protection
16%
Vaccine Dose
16%
Pharmacology, Toxicology and Pharmaceutical Science
Human Papillomavirus
100%
Condyloma acuminatum
100%
Wart Virus Vaccine
16%
Diseases
16%